AAPL327.17-5.85 (-1.76%) ▼|ABBV260.57-1.02 (-0.39%) ▼|ABT97.71-1.12 (-1.13%) ▼|ACN215.99+32.62 (+17.79%) ▲|ADBE238.15-1.80 (-0.75%) ▼|AMAT524.34+12.96 (+2.53%) ▲|AMD611.70-0.07 (-0.01%) ▼|AMGN411.82-9.69 (-2.30%) ▼|AMT162.27-1.42 (-0.87%) ▼|AMZN246.60-2.55 (-1.02%) ▼|AVGO346.77-4.42 (-1.26%) ▼|AXP299.25-4.85 (-1.59%) ▼|BA187.66+1.61 (+0.87%) ▲|BAC53.28-1.16 (-2.12%) ▼|BKNG160.87-2.04 (-1.25%) ▼|BLK1,060.01+1.72 (+0.16%) ▲|BMY61.61-0.80 (-1.27%) ▼|BNY142.38-2.25 (-1.56%) ▼|BRK-B498.66+0.71 (+0.14%) ▲|C124.88-4.60 (-3.55%) ▼|CAT816.26+5.47 (+0.67%) ▲|CL84.64-0.68 (-0.80%) ▼|CMCSA21.57-0.19 (-0.87%) ▼|COF191.42-1.65 (-0.85%) ▼|COP127.05+1.90 (+1.52%) ▲|COST921.34+11.00 (+1.21%) ▲|CRM231.09+1.52 (+0.66%) ▲|CSCO108.17+0.54 (+0.50%) ▲|CVS85.02-0.67 (-0.78%) ▼|CVX206.47+2.26 (+1.11%) ▲|DE661.04-10.51 (-1.57%) ▼|DHR216.15-5.41 (-2.44%) ▼|DIS101.77-3.13 (-2.98%) ▼|DUK113.45-0.56 (-0.49%) ▼|EMR157.02+1.92 (+1.23%) ▲|FDX286.68+1.59 (+0.56%) ▲|GD333.57+1.74 (+0.52%) ▲|GE312.12-0.18 (-0.06%) ▼|GEV966.63+16.14 (+1.70%) ▲|GILD147.82-1.23 (-0.83%) ▼|GM77.41+0.41 (+0.53%) ▲|GOOG337.08-3.66 (-1.07%) ▼|GOOGL340.16-3.93 (-1.14%) ▼|GS887.85-12.51 (-1.39%) ▼|HD279.64-4.86 (-1.71%) ▼|HON213.04+2.10 (+0.99%) ▲|IBM224.71+4.78 (+2.17%) ▲|INTC119.57-0.66 (-0.55%) ▼|INTU277.73+2.02 (+0.73%) ▲|ISRG401.89-4.75 (-1.17%) ▼|JNJ261.78-2.97 (-1.12%) ▼|JPM328.64-2.19 (-0.66%) ▼|KO86.29+0.21 (+0.24%) ▲|LIN463.35-11.30 (-2.38%) ▼|LLY1,146.55-10.53 (-0.91%) ▼|LMT507.31-1.94 (-0.38%) ▼|LOW180.58-3.71 (-2.01%) ▼|LRCX333.62+5.11 (+1.56%) ▲|MA549.13-2.34 (-0.42%) ▼|MCD230.83-0.11 (-0.05%) ▼|MDLZ57.87+0.05 (+0.09%) ▲|MDT85.95-0.34 (-0.39%) ▼|META728.30+3.12 (+0.43%) ▲|MMM163.24-0.92 (-0.56%) ▼|MO66.94-0.40 (-0.59%) ▼|MRK144.53-0.78 (-0.54%) ▼|MS184.16-3.92 (-2.08%) ▼|MSFT513.30+0.40 (+0.08%) ▲|MU1,051.17-13.94 (-1.31%) ▼|NEE75.73-0.01 (-0.01%) ▼|NFLX68.08-1.51 (-2.16%) ▼|NKE35.86+0.46 (+1.29%) ▲|NOW135.89+1.88 (+1.40%) ▲|NVDA229.22+0.84 (+0.37%) ▲|ORCL135.72-1.59 (-1.15%) ▼|PEP126.23-0.49 (-0.39%) ▼|PFE28.29-0.23 (-0.81%) ▼|PG143.93-1.35 (-0.93%) ▼|PLTR188.06+1.01 (+0.54%) ▲|PM187.83-2.99 (-1.57%) ▼|QCOM183.82-0.22 (-0.12%) ▼|RTX185.39-0.26 (-0.14%) ▼|SBUX94.06+0.10 (+0.11%) ▲|SCHW97.07-0.67 (-0.69%) ▼|SO82.22-0.67 (-0.81%) ▼|SPG199.42-1.34 (-0.67%) ▼|T24.45+0.05 (+0.18%) ▲|TMO664.09-10.97 (-1.62%) ▼|TMUS162.19-0.89 (-0.55%) ▼|TSLA357.06+2.25 (+0.63%) ▲|TXN279.83-0.26 (-0.09%) ▼|UBER67.75-0.77 (-1.12%) ▼|UNH363.39-3.69 (-1.01%) ▼|UNP270.08-2.05 (-0.75%) ▼|UPS93.63+0.19 (+0.20%) ▲|USB56.42-1.34 (-2.32%) ▼|V359.36+0.03 (+0.01%) ▲|VZ45.85-0.02 (-0.03%) ▼|WFC78.34-1.72 (-2.14%) ▼|WMT103.92+0.00 (+0.00%) ▲|XOM163.43+0.68 (+0.42%) ▲|AAPL327.17-5.85 (-1.76%) ▼|ABBV260.57-1.02 (-0.39%) ▼|ABT97.71-1.12 (-1.13%) ▼|ACN215.99+32.62 (+17.79%) ▲|ADBE238.15-1.80 (-0.75%) ▼|AMAT524.34+12.96 (+2.53%) ▲|AMD611.70-0.07 (-0.01%) ▼|AMGN411.82-9.69 (-2.30%) ▼|AMT162.27-1.42 (-0.87%) ▼|AMZN246.60-2.55 (-1.02%) ▼|AVGO346.77-4.42 (-1.26%) ▼|AXP299.25-4.85 (-1.59%) ▼|BA187.66+1.61 (+0.87%) ▲|BAC53.28-1.16 (-2.12%) ▼|BKNG160.87-2.04 (-1.25%) ▼|BLK1,060.01+1.72 (+0.16%) ▲|BMY61.61-0.80 (-1.27%) ▼|BNY142.38-2.25 (-1.56%) ▼|BRK-B498.66+0.71 (+0.14%) ▲|C124.88-4.60 (-3.55%) ▼|CAT816.26+5.47 (+0.67%) ▲|CL84.64-0.68 (-0.80%) ▼|CMCSA21.57-0.19 (-0.87%) ▼|COF191.42-1.65 (-0.85%) ▼|COP127.05+1.90 (+1.52%) ▲|COST921.34+11.00 (+1.21%) ▲|CRM231.09+1.52 (+0.66%) ▲|CSCO108.17+0.54 (+0.50%) ▲|CVS85.02-0.67 (-0.78%) ▼|CVX206.47+2.26 (+1.11%) ▲|DE661.04-10.51 (-1.57%) ▼|DHR216.15-5.41 (-2.44%) ▼|DIS101.77-3.13 (-2.98%) ▼|DUK113.45-0.56 (-0.49%) ▼|EMR157.02+1.92 (+1.23%) ▲|FDX286.68+1.59 (+0.56%) ▲|GD333.57+1.74 (+0.52%) ▲|GE312.12-0.18 (-0.06%) ▼|GEV966.63+16.14 (+1.70%) ▲|GILD147.82-1.23 (-0.83%) ▼|GM77.41+0.41 (+0.53%) ▲|GOOG337.08-3.66 (-1.07%) ▼|GOOGL340.16-3.93 (-1.14%) ▼|GS887.85-12.51 (-1.39%) ▼|HD279.64-4.86 (-1.71%) ▼|HON213.04+2.10 (+0.99%) ▲|IBM224.71+4.78 (+2.17%) ▲|INTC119.57-0.66 (-0.55%) ▼|INTU277.73+2.02 (+0.73%) ▲|ISRG401.89-4.75 (-1.17%) ▼|JNJ261.78-2.97 (-1.12%) ▼|JPM328.64-2.19 (-0.66%) ▼|KO86.29+0.21 (+0.24%) ▲|LIN463.35-11.30 (-2.38%) ▼|LLY1,146.55-10.53 (-0.91%) ▼|LMT507.31-1.94 (-0.38%) ▼|LOW180.58-3.71 (-2.01%) ▼|LRCX333.62+5.11 (+1.56%) ▲|MA549.13-2.34 (-0.42%) ▼|MCD230.83-0.11 (-0.05%) ▼|MDLZ57.87+0.05 (+0.09%) ▲|MDT85.95-0.34 (-0.39%) ▼|META728.30+3.12 (+0.43%) ▲|MMM163.24-0.92 (-0.56%) ▼|MO66.94-0.40 (-0.59%) ▼|MRK144.53-0.78 (-0.54%) ▼|MS184.16-3.92 (-2.08%) ▼|MSFT513.30+0.40 (+0.08%) ▲|MU1,051.17-13.94 (-1.31%) ▼|NEE75.73-0.01 (-0.01%) ▼|NFLX68.08-1.51 (-2.16%) ▼|NKE35.86+0.46 (+1.29%) ▲|NOW135.89+1.88 (+1.40%) ▲|NVDA229.22+0.84 (+0.37%) ▲|ORCL135.72-1.59 (-1.15%) ▼|PEP126.23-0.49 (-0.39%) ▼|PFE28.29-0.23 (-0.81%) ▼|PG143.93-1.35 (-0.93%) ▼|PLTR188.06+1.01 (+0.54%) ▲|PM187.83-2.99 (-1.57%) ▼|QCOM183.82-0.22 (-0.12%) ▼|RTX185.39-0.26 (-0.14%) ▼|SBUX94.06+0.10 (+0.11%) ▲|SCHW97.07-0.67 (-0.69%) ▼|SO82.22-0.67 (-0.81%) ▼|SPG199.42-1.34 (-0.67%) ▼|T24.45+0.05 (+0.18%) ▲|TMO664.09-10.97 (-1.62%) ▼|TMUS162.19-0.89 (-0.55%) ▼|TSLA357.06+2.25 (+0.63%) ▲|TXN279.83-0.26 (-0.09%) ▼|UBER67.75-0.77 (-1.12%) ▼|UNH363.39-3.69 (-1.01%) ▼|UNP270.08-2.05 (-0.75%) ▼|UPS93.63+0.19 (+0.20%) ▲|USB56.42-1.34 (-2.32%) ▼|V359.36+0.03 (+0.01%) ▲|VZ45.85-0.02 (-0.03%) ▼|WFC78.34-1.72 (-2.14%) ▼|WMT103.92+0.00 (+0.00%) ▲|XOM163.43+0.68 (+0.42%) ▲|
22 C
New York
Thursday, October 1, 2026

Tag: 1

newssourceFORcompanyinformationcontent1releasesmarket

Fapon Biopharma to Showcase Differentiated Pipeline, Including Phase 1 Immunocytokine FP008, and Innovative Technology Platforms at BIO 2025

BOSTON, June 12, 2025 /PRNewswire/ -- Fapon Biopharma, a clinical-stage biotech company innovating therapeutic antibodies and fusion proteins, is pleased to announce its participation...

Aquaporin appoints Chief Executive Officer

Company announcementNo. 09/2025 Inside information Aquaporin A/SNymøllevej 78DK-2800 Kongens Lyngbyaquaporin.comCompany registration no.: DK28315694 KONGENS LYNGBY, Denmark, June 12, 2025 /PRNewswire/ -- The Board of Directors of Aquaporin...

Medical Second Opinion Market to Hit USD 19.03 Billion by 2029, Driven by Cancer and Chronic Care | Valuates Reports

BANGALORE, India, June 12, 2025 /PRNewswire/ -- Medical Second Opinion Market is Segmented by Type (Hospitals, Medical Second Opinion Providing Companies, Health Insurance Companies),...

Primax-Tymphany Group Joins Microsoft Device Ecosystem Platform (MDEP) to Enhance Conferencing Technology

TAIPEI, June 12, 2025 /PRNewswire/ -- The Primax-Tymphany Group, a global leader in conferencing technology, is committed to delivering secure, flexible, and user-friendly conferencing products...

MemorialCare Long Beach Medical Center Recognized by Newsweek as One of America’s Best Hospitals in Cancer, Neurology, Orthopedics

LONG BEACH, Calif., June 12, 2025 /PRNewswire/ -- MemorialCare Long Beach Medical Center was named in Newsweek's 2025 America's Best Hospitals rankings in three...

TOMY Group Subsidiary T-ARTS to Release New Figure Series “PERIHAPI!” in Aug. as 1st Phase of Project to Commemorate 60th Anniversary of Gacha (R)’s...

- Project to Commemorate 60th Anniversary of Gacha (R)'s Introduction to Japan Kicked off Feb. 17 "Gacha's Day" - TOKYO, June 12, 2025 /PRNewswire/ --...

Orange: Orange intends to issue a new series of Euro-denominated hybrid notes and to launch a tender offer on some of its outstanding hybrid...

Press release
Paris, 12 June 2025

Orange : Orange a l’intention d’émettre une nouvelle souche d’obligations hybrides et de lancer une offre de rachat sur certaines de ses obligations hybrides...

Communiqué de presse
Paris, 12 juin 2025

Implantica announces new real-world Swiss study on 99 RefluxStop™ patients comparing small and large hiatal hernia, confirming equally excellent long-term results

VADUZ, Liechtenstein, June 12, 2025 /PRNewswire/ -- Implantica AG (publ.), a MedTech company at the forefront of introducing advanced technology into the body, including...

The Countdown Begins: Pre-Register Now for My Talking Tom Friends 2 by Outfit7

LIMASSOL, Cyprus , June 12, 2025 /PRNewswire/ -- The squad is back, and they're cooler than ever! Outfit7 is setting the stage for a bold...

Enterome raises $19 million to fund clinical development of its OncoMimics™ immunotherapy to treat Follicular Lymphoma

Paris, France – June 12, 2025

Enterome SA, a clinical-stage company developing first-in-class OncoMimics™ immunotherapies to treat cancer, has raised $19 million in a new private financing to advance its lead clinical program EO2463 OncoMimics™ immunotherapy to treat indolent non-Hodgkin lymphoma (iNHL). The new funds will be used to expand and finalize the ongoing Phase 1/2 SIDNEY clinical trial of EO2463 and prepare the candidate for a registrational trial.

Aerospace and defense leaders are prioritizing digital continuity to tackle industry disruption

Press contact: 
Florence Lièvre
Tel.: +33 1 47 54 50 71
Email: florence.lievre@capgemini.com

Clariane completes its plan to strengthen its financial structure with the disposal of its Petits-fils home care services network

        

Clariane finalise le plan de renforcement de sa structure financière avec la cession son réseau d’aide à domicile Petits-fils

        

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTags1

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers